Health Affairs Scholar · 2023 · 31 citations · 16 references
PharmacyPharmaceutical PolicyPharmacotherapyControlled Substance PolicyPharmaceutical RegulationSubstance Use DisordersDispensing RegulationsOpioid PolicyOpioid RegulationPrescription Drug Dispensing RequirementsPrescription Drug PolicyPrescription RegulationMethadone Dispensing RegulationMethadone Maintenance TreatmentMethadone RegulationOpioid Control PolicyOpioid Dispensing RestrictionsOpioid Treatment Program RegulationOpioid Use Disorder Treatment AccessPharmacy Dispensing Regulations
For 5 decades, US federal regulations have segregated methadone treatment for opioid use disorder from the rest of the health care system, confining its availability to specialty treatment programs that are highly regulated. These regulations have led to severe shortages in the availability of methadone and grave underutilization of this lifesaving medication despite a worsening overdose crisis. In this commentary, we discuss current barriers to methadone in the US opioid treatment system and how recent changes to federal regulations fall short of the reforms needed to significantly expand access to this treatment. Instead, we propose the urgent need to expand methadone to mainstream health care settings by allowing for office-based prescribing and pharmacy dispensing of methadone, the norm in many other developed countries.
16
White opioids: Pharmaceutical race and the war on drugs that wasn’t
Julie Netherland, Helena Hansen · BioSocieties · 2016 · 297 citations · Full text
Law, Pharmacology, Drug Law +9
David Frank, Pedro Mateu‐Gelabert, David C. Perlman et al. · Harm Reduction Journal · 2021 · 180 citations · Full text